Search

Your search keyword '"Berg, Christine D"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Berg, Christine D" Remove constraint Author: "Berg, Christine D" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
56 results on '"Berg, Christine D"'

Search Results

1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

2. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

3. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

4. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

5. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

6. Body mass index and breast cancer survival:a Mendelian randomization analysis

7. Body mass index and breast cancer survival:a Mendelian randomization analysis

8. ABO blood group alleles and prostate cancer risk : Results from the breast and prostate cancer cohort consortium (BPC3)

9. ABO blood group alleles and prostate cancer risk : Results from the breast and prostate cancer cohort consortium (BPC3)

10. ABO blood group alleles and prostate cancer risk : Results from the breast and prostate cancer cohort consortium (BPC3)

11. ABO Blood Group Alleles and Prostate Cancer Risk : results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

12. Vitamin D-Associated Genetic Variation and Risk of Breast Cancer in the Breast and Prostate Cancer Cohort Consortium (BPC3)

13. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

14. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.

15. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

16. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

17. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.

18. ABO blood group alleles and prostate cancer risk : Results from the breast and prostate cancer cohort consortium (BPC3)

19. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

20. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

21. ABO blood group alleles and prostate cancer risk : Results from the breast and prostate cancer cohort consortium (BPC3)

22. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

23. A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer

24. A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer

25. A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer

26. Post-G WAS gene-environment interplay in breast cancer : results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women

27. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

28. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium

29. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

30. A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer

31. A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer

32. Detectable clonal mosaicism and its relationship to aging and cancer

33. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23

34. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

35. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

36. Detectable clonal mosaicism and its relationship to aging and cancer.

37. Cancer screening: the journey from epidemiology to policy.

38. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

39. Cancer screening: the journey from epidemiology to policy.

40. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

41. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

42. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

43. Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium

44. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

45. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.

46. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer

47. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

48. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

49. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

50. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.

Catalog

Books, media, physical & digital resources